Swiss Life Sciences Trend Analysis 2014

While the number of Swiss Biotech companies in 2013 remained close to its 2012 levels, the total financing value amassed within the sector more than doubled compared to last year’s figure, reaching USD 325m (112% increase). Click here to download Swiss Life Sciences Trend Analysis 2014 – 14 pages Looking for your next Biotech or … Continue reading Swiss Life Sciences Trend Analysis 2014

Read more

Spanish Life Sciences Trend Analysis 2014

Biotech financing activity in Spain in 2013 was slower compared to 2012 (43% fewer financing rounds and no IPOs). Nevertheless, the total financing value raised by Biotechs increased by approximately 10% during the same period. Click here to download Spanish Life Sciences Trend Analysis 2014 – 14 pages Looking for your next Biotech or Medtech … Continue reading Spanish Life Sciences Trend Analysis 2014

Read more

Biotechgate launches Investor Database

ZURICH, August 2014: Biotechgate announces the launch of a new database which provides information on investors seeking investment opportunities within the life science industry. With the help of the database, capital raising companies can identify specific investors and retrieve the contact details of the responsible persons. The new Biotechgate Investor Database is a life science-specific … Continue reading Biotechgate launches Investor Database

Read more